News & Press

CordenPharma COVID-19 Customer Letter

September 14, 2020
COVID-19 > Read CEO Dr. Micheal Quirmbach's Customer Letter Response to COVID-19.

CordenPharma’s Weekly Update to COVID-19 (Novel Coronavirus)

Please Read CEO & President Dr. Michael Quirmbach’s Letter to Customers

Watch our COVID-19 Video Updates and Success Stories Here

Please click here to inform us of any urgent questions or concerns regarding COVID-19


Dear Valued Customer,

Due to the reduction of COVID-19 cases being seen in Europe, and as the EU cautiously starts to re-open its borders, I am pleased to announce that we will soon start to allow site visits at some of our facilities, although at a reduced frequency. Obviously these visits will only move forward in alignment with local governmental regulations and under strict Standard Operating Procedures. Please contact your Key Account Manager to understand which sites are accepting customer visits & audits, facilitate scheduling and review the specific guidelines you will need to follow upon visitation.

At this current time, our Boulder, CO US facilities and certain Italian operations remain closed for site visits until further notice. We will inform you of any changes as they unfold.

In addition, the European Key Account Sales team will start scheduling customer visits where possible, and in alignment with local guidelines.

I am glad to report that through the consistent efforts and hard work of all CordenPharma employees at the site level, we have experienced minimal disruptions to our regular operations. Our global facilities are working diligently to make additional capacity available that is particularly suited for COVID-19 treatment & vaccine development, such as the manufacturing of key APIs (e.g. Lipid Excipients) used for drug delivery formulations and Sterile Injectable Drug Product lines for the filling of new vaccines.

Rest assured that all CordenPharma employees, from the Executive Leadership Team and Facility Managing Directors, to the Marketing & Sales Team and Operators, are aligned and committed to mitigating any impact on delivering your critical, often lifesaving, medications. We are doing everything possible on our end to support your patients through this crisis.

We appreciate your patience as we react to this global issue, and thank you for your ongoing support in returning to “business as usual” as quickly as possible. Feel free to reach out to your Key Account Managers or fill out this form with any questions or concerns.

I wish you and your families stay safe & healthy, as we continue to work together as a collective community to support business continuity and each other.

Best Regards,

Dr. Michael Quirmbach
Chief Executive Officer & President
CordenPharma